gel supershift Search Results


dna mobility shift assays  (New England Biolabs)
99
New England Biolabs dna mobility shift assays
Dna Mobility Shift Assays, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna mobility shift assays/product/New England Biolabs
Average 99 stars, based on 1 article reviews
dna mobility shift assays - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
an electrophoretic mobility shift assay (emsa) kit  (Viagene Inc)
90
Viagene Inc an electrophoretic mobility shift assay (emsa) kit
An Electrophoretic Mobility Shift Assay (Emsa) Kit, supplied by Viagene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an electrophoretic mobility shift assay (emsa) kit/product/Viagene Inc
Average 90 stars, based on 1 article reviews
an electrophoretic mobility shift assay (emsa) kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
drug-tolerant homogeneous mobility shift assay  (Prometheus Laboratories)
90
Prometheus Laboratories drug-tolerant homogeneous mobility shift assay
Drug Tolerant Homogeneous Mobility Shift Assay, supplied by Prometheus Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/drug-tolerant homogeneous mobility shift assay/product/Prometheus Laboratories
Average 90 stars, based on 1 article reviews
drug-tolerant homogeneous mobility shift assay - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
p-cadherin promoter region containing the mutated p2 site (pp-cad-p1p2*p3)  (GenScript corporation)
90
GenScript corporation p-cadherin promoter region containing the mutated p2 site (pp-cad-p1p2*p3)
P Cadherin Promoter Region Containing The Mutated P2 Site (Pp Cad P1p2*P3), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-cadherin promoter region containing the mutated p2 site (pp-cad-p1p2*p3)/product/GenScript corporation
Average 90 stars, based on 1 article reviews
p-cadherin promoter region containing the mutated p2 site (pp-cad-p1p2*p3) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
electrophoretic-mobility shift assay (emsa) kit gs-0030  (Signosis Inc)
90
Signosis Inc electrophoretic-mobility shift assay (emsa) kit gs-0030
Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) <t>EMSA</t> showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.
Electrophoretic Mobility Shift Assay (Emsa) Kit Gs 0030, supplied by Signosis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrophoretic-mobility shift assay (emsa) kit gs-0030/product/Signosis Inc
Average 90 stars, based on 1 article reviews
electrophoretic-mobility shift assay (emsa) kit gs-0030 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
electrophoretic mobility shift assay emsa nf κb dna binding activity  (Thermo Fisher)
99
Thermo Fisher electrophoretic mobility shift assay emsa nf κb dna binding activity
Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) <t>EMSA</t> showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.
Electrophoretic Mobility Shift Assay Emsa Nf κb Dna Binding Activity, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrophoretic mobility shift assay emsa nf κb dna binding activity/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
electrophoretic mobility shift assay emsa nf κb dna binding activity - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
electrophoretic mobility shift assay dna binding reactions  (Thermo Fisher)
99
Thermo Fisher electrophoretic mobility shift assay dna binding reactions
Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) <t>EMSA</t> showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.
Electrophoretic Mobility Shift Assay Dna Binding Reactions, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrophoretic mobility shift assay dna binding reactions/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
electrophoretic mobility shift assay dna binding reactions - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
electric mobility shift assay stat3 consensus sequence  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology electric mobility shift assay stat3 consensus sequence
Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) <t>EMSA</t> showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.
Electric Mobility Shift Assay Stat3 Consensus Sequence, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electric mobility shift assay stat3 consensus sequence/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
electric mobility shift assay stat3 consensus sequence - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
electrophoretic mobility shift assay  (Promega)
90
Promega electrophoretic mobility shift assay
Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) <t>EMSA</t> showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.
Electrophoretic Mobility Shift Assay, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrophoretic mobility shift assay/product/Promega
Average 90 stars, based on 1 article reviews
electrophoretic mobility shift assay - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
anti human p65 supershift antibodies  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology anti human p65 supershift antibodies
Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) <t>EMSA</t> showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.
Anti Human P65 Supershift Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human p65 supershift antibodies/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
anti human p65 supershift antibodies - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
transcruz gel supershift anti hes 1 antibodies  (Santa Cruz Biotechnology)
95
Santa Cruz Biotechnology transcruz gel supershift anti hes 1 antibodies
Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) <t>EMSA</t> showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.
Transcruz Gel Supershift Anti Hes 1 Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transcruz gel supershift anti hes 1 antibodies/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
transcruz gel supershift anti hes 1 antibodies - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
electrophoretic mobility shift assay emsa  (Thermo Fisher)
99
Thermo Fisher electrophoretic mobility shift assay emsa
Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) <t>EMSA</t> showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.
Electrophoretic Mobility Shift Assay Emsa, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrophoretic mobility shift assay emsa/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
electrophoretic mobility shift assay emsa - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

Image Search Results


Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) EMSA showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.

Journal: International Journal of Molecular Sciences

Article Title: Perineural Dexmedetomidine Attenuates Inflammation in Rat Sciatic Nerve via the NF-κB Pathway

doi: 10.3390/ijms15034049

Figure Lengend Snippet: Perineural administration of 20 μg/kg dexmedetomidine decreased the translocation to the nucleus and transcriptional binding activity of NF-κB. ( A ) Western blot showed that 20 μg/kg dexmedetomidine decreased NF-κB translocation into the nucleus; ( B ) Dexmedetomidine (20 μg/kg) decreased the nuclear NF-κB protein level; ( C ) Dexmedetomidine (20 μg/kg) did not alter the total NF-κB protein level; ( D ) EMSA showed that 20 μg/kg dexmedetomidine decreased the transcriptional binding activity of NF-κB (lane 3); PDTC also decreased NF-κB transcriptional binding activity (lane 5). NF-κB, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate.

Article Snippet: An electrophoretic-mobility shift assay (EMSA) kit (GS-0030, Signosis, Santa Clara, CA, USA) was used to assess the transcriptional binding activity of NF-κB as a previous study described [ ].

Techniques: Translocation Assay, Binding Assay, Activity Assay, Western Blot